BILL ANALYSIS

HR1267

BULLISH

Water Systems PFAS Liability Protection Act

HR1267 (Water Systems PFAS Liability Protection Act) has been assessed with a bullish outlook for investors. The primary sectors impacted are Utilities and Materials. View the full bill text on Congress.gov.

bullish

Market Sentiment

5/10

Impact Score

Sectors Impacted

Key Takeaways for Investors

HR1267 is early-stage (referred to subcommittee Feb 2025, no action since) — low probability of near-term passage.

The bill shifts PFAS CERCLA liability from water utilities to chemical manufacturers; no federal funds are authorized or appropriated.

Water utility stocks ($WTRG, $CWT) show no price reaction linked to this bill — recent declines are likely sector-driven.

Chemical manufacturer stocks ($DD, $MMM) face potential increased liability concentration if bill advances, but current prices reflect no such premium.

No Senate companion bill exists, and the bill has not moved in 14 months — monitor committee activity for progress.

Real market data shows ALL four tickers near or below their 52-week midpoints, with negative 7-day momentum across the board.

How HR1267 Affects the Market

The market has priced in zero probability of near-term passage for HR1267. Water utility stocks $WTRG ($39.49) and $CWT ($45.38) trade with negative 7-day momentum (-2.08% and -4.5%, respectively) consistent with broader utility sector headwinds from interest rate expectations, not PFAS legislation. Chemical manufacturers $DD ($44.62) and ($143.87) trade near the lower end of their 52-week ranges, reflecting other company-specific factors (DuPont's ongoing restructuring; 3M's litigation overhang and PFAS settlements). If the bill gains momentum — subcommittee passage, full committee markup, or a Senate companion introduction — expect a modest positive reaction in water utility stocks (liability removal) and a modest negative reaction in chemical manufacturers (liability concentration). However, at current early-stage status, the signal is negligible. Investors should watch for: (1) any House Energy & Commerce or Transportation & Infrastructure committee markup, (2) a Senate companion bill (likely from a bipartisan pair including a Democrat from a PFAS-affected state), and (3) EPA PFAS regulatory updates that could add urgency to the legislation.

Bill Details

Metric	Value
Bill Number	HR1267
Market Sentiment	bullish
Event Date	February 12, 2025
Affected Sectors	Utilities, Materials
Source	View on Congress.gov →

Summary

HR1267 is an early-stage bill exempting water utilities from CERCLA liability for PFAS, shifting cleanup costs to chemical manufacturers. The bill is in committee with 26 cosponsors and no floor action. Water utility stocks ($WTRG at $39.49, $CWT at $45.38) show mixed near-term trends; no market reaction to this bill is observable. Chemical manufacturers $DD at $44.62 and $MMM at $143.87 face potential increased liability exposure but remain near their 52-week ranges.

Full AI Market Analysis

1) What happened and current status: HR1267, the Water Systems PFAS Liability Protection Act, was introduced in the House on February 12, 2025, by Rep. Marie Gluesenkamp Perez (D-WA). It has 26 cosponsors and has been referred to two committees: Energy and Commerce, and Transportation and Infrastructure. It has been further referred to the Subcommittee on Water Resources and Environment. No further action has occurred in the 14+ months since introduction. The bill is in early committee stage — typical for the 119th Congress (2025–2027). No companion bill in the Senate has been identified. 2) The money trail: This bill does NOT authorize or appropriate any federal funding. Its mechanism is purely regulatory relief: it exempts specified water entities from CERCLA liability for PFAS releases, meaning they cannot be sued for cost recovery or damages under federal Superfund law. The financial impact comes from shifting liability — water utilities avoid clean-up costs that would otherwise fall on them, while chemical manufacturers retain liability and may face higher cleanup cost exposure. No actual dollars are allocated by this bill. 3) Structural winners and losers: Winners are water utilities ($WTRG, $CWT) that would avoid potential CERCLA liability for PFAS in their systems. The bill protects public water systems, treatment works, stormwater permit holders, wholesale water agencies, and their contractors. Losers are chemical manufacturers who historically produced PFAS: $DD (DuPont, with legacy PFOA and PFAS liabilities from its chemical and spin-off history), (3M, manufacturer of PFAS for decades with ~$12.5 billion in existing settlements), and potentially $CTVA (Corteva, agriculture spinoff from DowDuPont with some legacy exposure) and $EMN (Eastman Chemical, though less direct). The bill concentrates liability on manufacturers because water utilities — typically deep-pocket defendants in PFAS litigation — would be removed as targets. 4) Real market data analysis: As of April 30, 2026, $WTRG trades at $39.49, down 2.08% over 7 days and 3.8% over 30 days, near the midpoint of its 52-week range ($36.32–$42.37). $CWT trades at $45.38, down 4.5% over 7 days and 1.45% over 30 days, below its 52-week midpoint of ~$46.22. $DD trades at $44.62, down 3.77% over 7 days but up 0.9% over 30 days, well below its 52-week high of $52.66. trades at $143.87, down 0.67% over 7 days and up 0.95% over 30 days, near the bottom of its 52-week range of $137.63–$177.41. No price movements are attributable to this bill, given its early-stage, low-probability status. The 30-day declines in water utilities likely reflect broader sector dynamics (interest rate sensitivity, regulatory uncertainty) rather than PFAS legislation specifically. 5) Timeline: The bill has been stalled in subcommittee since February 2025. For it to become law, it would need: subcommittee markup, full committee markups in two committees (Energy & Commerce; Transportation & Infrastructure), House floor passage, Senate introduction and passage (no companion bill exists yet), and Presidential signature. With 26 cosponsors on a bipartisan bill (Perez is Democrat; original cosponsor Maloy is Republican), there is some cross-aisle appeal, but the 14-month stall suggests low current priority. Likelihood of passage in the 119th Congress is low to moderate at best, and any impact would be contingent on future action.